However, other studies provide evidence pointing towards the fact that IL-6 blockade would be more useful for the arthritis component of the disease [12, 31, 32], and still others suggest that the efficacy of IL-1 blockade would be limited to the systemic features of the disease [33–35]. This evidence concerns the gene IL1B and arthritic joint disease.